Goldman Sachs Initiates Coverage on Bayer Stock with Neutral Rating and €31 Target
Friday, 31 May 2024, 11:08
Goldman Sachs Initiates Coverage on Bayer Stock
Goldman Sachs recently initiated coverage on Bayer stock, assigning a Neutral rating with a price target of €31. This move provides insight into the investment bank's outlook on Bayer's performance in the near future. Investors are advised to monitor upcoming developments closely to assess the stock's movement and potential opportunities.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.